How much revenue does PExA AB (publ) make?

PExA AB (publ) reported 477,683 SEK in revenue for fiscal year 2025, down 33.6% from 719,619 SEK in fiscal year 2024. In Q2 2026 revenue was 82,800 SEK.

What companies are similar to PExA AB (publ)?

Listed companies of a similar size in the same industry (targeted healthcare equipment) include OssDsign AB (publ) (OSSD.ST), SciBase Holding AB (publ) (SCIB.ST), Clinical Laserthermia Systems AB (publ) (CLS-B.ST), Redsense Medical AB (REDS.ST).

PExA AB (publ) (PEXA-B.ST) Stock

About PExA AB (publ)

PExA AB (publ) develops and commercializes diagnostic products for various respiratory diseases. It offers products for asthma, tuberculosis, cystic fibrosis, lung cancer, and chronic obstructive pulmonary disease. The company's research instrument helps lung researchers in the collection of microscopic particles and biomarkers for diseases in the small airways. It offers PExA 2.0, an instrument f...

At a glance

PExA AB (publ) reported revenue of 477,683 SEK for fiscal year 2025, down 33.6% from fiscal year 2024, and net income of -6.25 million SEK. In Q2 2026 (the quarter ended June 30, 2026) revenue was 82,800 SEK, down 73.5% from a year before.

Figures from company filings; latest fiscal year ended December 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.